Nutsa Burduli

Artiklar

Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2024;43(1):13

Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.

Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam K-P; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(10):e005308

Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells.

Neo SY; Jing X; Tong L; Tong D; Gao J; Chen Z; De Los Santos MC; Burduli N; De Souza Ferreira S; Wagner AK; Alici E; Rolny C; Cao Y; Lundqvist A

Meeting abstract: BLOOD. 2019;134:5536

Targeting CD38^high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Nolan E; Stikvoort A; Gurney M; Burduli N; Kirkham-McCarthy L; Daly J; Van de Donk NWCJ; Mutis T; Sarkar S; O'Dwyer ME

Master of Science, Cancer research, Development of genetically engineered Natural Killer cells for the treatment of Pancreatic Cancer, Medicine, National University of Ireland, Galway, 2019
Bachelor of Science, Biochemistry, Mutation of a key enzyme residue in MSH3 subunit of MutSβ to inactivate its enzymatic function, Biological and Chemical Sciences, National University of Ireland, Galway, 2015